Roca Therapeutics
- 26/09/2022
- Seed
- Undisclosed Amount
First In Class Drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation
- Industry Biotechnology Research
- Website http://www.roca-therapeutics.org/
- LinkedIn https://www.linkedin.com/company/roca-therapeutics/
Related People
Maeva DufiesFounder
I obtained my doctorate (2012) and my accreditation to supervise research (HDR, 2019) at the University of Nice. I have over ten years of experience in oncology and translational research. I am an expert in the study of the resistance to treatment of several cancers. I developed a network with many clinicians and Pharmas. I have won several prizes: "Super-Heroes of Innovation" (SATT Sud-Est, 2020), ARTuR prize (association for research on kidney tumors, 2019), Michel Hery prize (Biennale Monégasque du Cancer, 2018 ), winner of the Prix d'Excellence of the Université Côte d'Azur (2016), Laureate of the Groupe Pasteur Mutualité (2016). I published 45 articles with an H factor of 17, contributed to the invention of 6 patents.
Wanting to valorize my research and bring it to patients in the hope of giving them another chance, I decided to embark on the adventure of creating a start-up, Roca Therapeutics. It is a new vision of the project with new challenges that I wish to succeed and which will meet a real and vital need for patients. This is why I followed various training courses on business creation.